Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Clinical trial NCT00384930 · COMPLETED
Trial details
- NCT number
- NCT00384930
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2007-10-01
- Enrollment
- 1058
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.